Collegium Pharmaceutical (COLL) Total Debt Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) Total Debt Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 41.53% |
| 10 | Collegium Pharmaceutical | 879.69 Mn | 730.37 Mn | 110.29 Mn | 45.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.72% |
| Mar 31, 2026 | 0.73% |
| Dec 31, 2025 | -7.18% |
| Sep 30, 2025 | -19.78% |
| Jun 30, 2025 | 85.10% |
| Mar 31, 2025 | 55.33% |
| Dec 31, 2024 | 51.91% |
| Sep 30, 2024 | 40.31% |
| Jun 30, 2024 | -35.90% |
| Mar 31, 2024 | -32.84% |
| Dec 31, 2023 | -27.68% |
| Sep 30, 2023 | -22.94% |
| Jun 30, 2023 | -18.57% |
| Mar 31, 2023 | -14.53% |
| Dec 31, 2022 | 409.07% |
| Sep 30, 2022 | 377.94% |
| Jun 30, 2022 | 352.47% |
| Mar 31, 2022 | 331.26% |
| Dec 31, 2021 | -30.15% |
| Sep 30, 2021 | -27.94% |